アメリカの医薬品産業プロファイルでは、市場シェア、市場規模(2017 〜 2022 年の値、および 2027 年までの予測)などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Merck & Co., Inc.
8.3. Pfizer Inc.
8.4. AstraZeneca PLC
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States pharmaceuticals market value: $ billion, 2017-22
Table 2: United States pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: United States pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Johnson & Johnson: key facts
Table 5: Johnson & Johnson: Annual Financial Ratios
Table 6: Johnson & Johnson: Key Employees
Table 7: Johnson & Johnson: Key Employees Continued
Table 8: Merck & Co., Inc.: key facts
Table 9: Merck & Co., Inc.: Annual Financial Ratios
Table 10: Merck & Co., Inc.: Key Employees
Table 11: Merck & Co., Inc.: Key Employees Continued
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
Table 16: AstraZeneca PLC: key facts
Table 17: AstraZeneca PLC: Annual Financial Ratios
Table 18: AstraZeneca PLC: Key Employees
Table 19: AstraZeneca PLC: Key Employees Continued
Table 20: United States size of population (million), 2018-22
Table 21: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 22: United States gdp (current prices, $ billion), 2018-22
Table 23: United States inflation, 2018-22
Table 24: United States consumer price index (absolute), 2018-22
Table 25: United States exchange rate, 2018-22
List of Figures
Figure 1: United States pharmaceuticals market value: $ billion, 2017-22
Figure 2: United States pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: United States pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in the United States, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in the United States, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in the United States, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2022